HEAT Trial (HER2 Antibody Therapy With Lutetium-177)

Clinical trial NCT06824155 · RECRUITING

Trial details

NCT number: NCT06824155
Sponsor: Radiopharm Theranostics, Ltd
Status: RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

HER2 Gene Mutation Advanced Solid Tumors

Start date: 2025-02-12
Primary completion: 2027-12-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.